2-Deoxy-glucose ameliorates the peritoneal mesothelial and endothelial barrier function perturbation occurring due to Peritoneal Dialysis fluids exposure

Peritoneal dialysis (PD) and prolonged exposure to PD fluids (PDF) induce peritoneal membrane (PM) fibrosis and hypervascularity, leading to functional PM degeneration. 2-deoxy-glucose (2 -DG) has shown potential as PM antifibrotic by inhibiting hyper-glycolysis induced mesothelial-to-mesenchymal transition (MMT). We investigated whether administration of 2 -DG with several PDF affects the permeability of mesothelial and endothelial barrier of the PM. The antifibrotic effect of 2 -DG was confirmed by the gel contraction assay with embedded mesothelial (MeT5A) or endothelial (EA.hy926) cells cultured in Dianeal (R) 2.5 % (CPDF), BicaVera (R) 2.3 % (BPDF), Balance (R) 2.3 % (LPDF) with/without 2 -DG addition (0.2 mM), and qPCR for alpha SMA, CDH2 genes. Moreover, 2 -DG effect was tested on the permeability of monolayers of mesothelial and endothelial cells by monitoring the transmembrane resistance (RTM), FITC-dextran (10, 70 kDa) diffusion and mRNA expression levels of CLDN-1 to -5, ZO1, SGLT1, and SGLT2 genes. Contractility of MeT-5A cells in CPDF/2-DG was decreased, accompanied by alpha SMA (0.17 +/- 0.03) and CDH2 (2.92 +/- 0.29) gene expression fold changes. Changes in alpha SMA, CDH2 were found in EA.hy926 cells, though alpha SMA also decreased under LPDF/2-DG incubation (0.42 +/- 0.02). Overall, 2 -DG mitigated the PDFinduced alterations in mesothelial and endothelial barrier function as shown by RTM, dextran transport and expression levels of the CLDN-1 to -5, ZO1, and SGLT2. Thus, supplementation of PDF with 2 -DG not only reduces MMT but also improves functional permeability characteristics of the PM mesothelial and endothelial barrier.